Lung Cancer

All articles by Lung Cancer

Tagrisso plus chemo approved in U.S. for lung cancer
Tagrisso plus chemo approved in U.S. for lung cancer
Marc Iskowitz
February 21, 2024
10:00 am

The FDA greenlit the Tagrisso/chemo regimen in treatment-naive EGFR-mutant NSCLC, bolstering AstraZeneca’s flagship brand against would-be rivals.

Bristol Myers Squibb buys SystImmune’s lung cancer drug for $800M upfront
Bristol Myers Squibb buys SystImmune’s lung cancer drug for $800M upfront
Jack O'Brien
December 12, 2023
10:51 am

The ADC-focused deal between Bristol Myers Squibb and SystImmune could amount to $8.4 billion in total potential consideration.

Legend Biotech exec details $100M lung cancer treatment deal with Novartis
Legend Biotech exec details $100M lung cancer treatment deal with Novartis
Jack O'Brien
November 16, 2023
4:22 pm

Legend’s subsidiary is licensing LB2102 and other potential CAR-T cell therapies targeting Delta-like ligand protein 3 to Novartis for $100 million upfront with the potential to receive up to $1.1 billion in milestone payments.

Could J&J’s Rybrevant-based combo disrupt AstraZeneca’s Tagrisso in lung cancer faceoff?
Could J&J’s Rybrevant-based combo disrupt AstraZeneca’s Tagrisso in lung cancer faceoff?
Marc Iskowitz
October 18, 2023
4:24 pm

J&J’s Rybrevant-based combo could take share from AstraZeneca’s Tagrisso in EGFR-mutant lung cancer, initial data suggest. Just how much will be the subject of debate.

Merck turns to testimonials to encourage lung-cancer screenings
Merck turns to testimonials to encourage lung-cancer screenings
Eric Berger
November 2, 2022
1:32 pm

The New Jersey-based pharma company, which makes the treatment Keytruda, worked with Real Chemistry on the campaign.

Ad Council fights lung cancer with ‘Saved By The Scan’ campaign
Ad Council fights lung cancer with ‘Saved By The Scan’ campaign
Oliver McAteer
November 8, 2019
2:12 pm

It’s the leading cancer killer of women and men.

American Lung Association turns cancer into a true crime killer
American Lung Association turns cancer into a true crime killer
Alison Kanski
November 12, 2018
9:28 am

The organization’s latest awareness campaign is taking cues from true crime shows.

Five things for pharma marketers to know: Wednesday, January 17, 2018
Five things for pharma marketers to know: Wednesday, January 17, 2018
Virginia Lau
January 17, 2018
3:20 pm

Celgene reportedly in talks to buy Juno; Novartis’ Kymriah receives fast-track reviews in U.S. and Europe; BI’s Gilotrif gets expanded approval in lung cancer

Five things for pharma marketers to know: Friday, February 24, 2017
Five things for pharma marketers to know: Friday, February 24, 2017
Virginia Lau
February 24, 2017
3:45 pm

PBMs’ use of “clawbacks” prompt lawsuits; Merck’s experimental antiviral drug prevents infection; EMA recommends Novartis’ lung-cancer combo drug

Marketers take a new approach to lung-cancer campaigns, and why that matters
Marketers take a new approach to lung-cancer campaigns, and why that matters
Larry Dobrow
February 6, 2017
10:15 pm

Each of the approaches is valid and more ambitious than a great majority of the campaigns that preceded them.

  • From Our Partners